Old Web
English
Sign In
Acemap
>
authorDetail
>
Elisabeth Luporsi-Gely
Elisabeth Luporsi-Gely
Medicine
Pathology
Biosimilar
Physical therapy
Anemia
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Epoetin biosimilars in the management of anemia secondary to chemotherapy in patients with solid tumors, lymphomas, and myelomas: The ORHEO study.
2017
Journal of Clinical Oncology
Elisabeth Luporsi-Gely
P. Soubeyran
Mauricette Michallet
Show All
Source
Cite
Save
Citations (0)
Epoetin biosimilars in the management of chemotherapy-induced anemia in elderly patients: A subanalysis of the ORHEO study.
2017
Journal of Clinical Oncology
Jean-Emmanuel Kurtz
P. Soubeyran
Mauricette Michallet
Elisabeth Luporsi-Gely
Show All
Source
Cite
Save
Citations (0)
Checking HER2 rates in breast cancer: A 4 year-experience with a nationwide database containing 105,717 records—HER-France.
2016
Journal of Clinical Oncology
Marie-Pierre Chenard
Eric Anger
Marie-Hélène Bizollon
Jerome Chetritt
Jean Kapfer
Magali Lacroix
Catherine Lefebvre
Eve Lefort
Elisabeth Luporsi-Gely
Gaëtan Mac Grogan
Julien Palasse
Thomas Petit
B Poulet
Vincent Rouleau
Emmanuel Watkin
C. Egele
Jean-Pierre Bellocq
Show All
Source
Cite
Save
Citations (0)
MGMT (06-methylguanine-DNA methyltransferase) promoter hypermethylation in the context of colorectal cancer.
2015
Journal of Clinical Oncology
Elisabeth Luporsi-Gely
Amandine Cadènes
Myriam Bronner
Hélène de Romémont
Dominique Saint Dizier
Ludovic Mansuy
Pierre Lehair
Philippe Jonveaux
Show All
Source
Cite
Save
Citations (0)
1